The Strides-backed protein and peptide-based therapeutics developer has disclosed a $70m series B and $125m C round, valuing it at $350m post-money.

The e-commerce marketing software provider boosted its valuation to $1.4bn in a round that included Access Industries' Claltech subsidiary.

Swisscom, BNY Mellon and SVB Financial Group have invested in a round that boosted the the digital asset infrastructure provider's overall funding to $179m.

Novartis and Bristol Myers Squibb helped the alpha radiotherapy developer complete a series A round after being incubated by MPM Capital.

Ubisoft, Warner Music Group, Intel Capital and Liberty Technology Venture Capital helped the game development platform provider secure $52.5m.

Prologis Ventures was among the participants in a round that will help the safety technology developer double the size of its team.

Madryn Asset Management has provided debt and equity financing intended to help Abbott-backed Bigfoot Biomedical bring its diabetes management technology to market.

VIB’s antiviral treatment developer has closed its series A round following a $22.6m extension backed by the research institute, V-Bio Ventures and Vives Inter-University Fund.

UCB’s corporate venture capital unit has helped the antiviral treatment developer close its series A round, joining a $22.6m extension.

The Cisco-backed marketing automation software provider has now secured more than $92m in funding altogether.